Cargando…

Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike

[Image: see text] Severe acute respiratory syndrome coronavirus 2 is the causative pathogen of the COVID-19 pandemic which as of March 29, 2021, has claimed 2 776 175 lives worldwide. Vaccine development efforts focus on the viral trimeric spike glycoprotein as the main target of the humoral immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brun, Juliane, Vasiljevic, Snežana, Gangadharan, Bevin, Hensen, Mario, V. Chandran, Anu, Hill, Michelle L., Kiappes, J.L., Dwek, Raymond A., Alonzi, Dominic S., Struwe, Weston B., Zitzmann, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029450/ https://www.ncbi.nlm.nih.gov/pubmed/34056088 http://dx.doi.org/10.1021/acscentsci.1c00058

Ejemplares similares

Exploring the Potential of Iminosugars as Antivirals for Crimean-Congo Haemorrhagic Fever Virus, Using the Surrogate Hazara Virus: Liquid-Chromatography-Based Mapping of Viral N-Glycosylation and In Vitro Antiviral Assays
por: Tyrrell, Beatrice E., et al.
Publicado: (2023)

The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking
por: Asor, Roi, et al.
Publicado: (2022)

Iminosugar antivirals: the therapeutic sweet spot
por: Alonzi, Dominic S., et al.
Publicado: (2017)

ToP-DNJ, a Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II Exhibiting Antiflaviviral Activity
por: Kiappes, J. L., et al.
Publicado: (2017)

Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases—Not Glycolipid Processing Enzymes
por: Sayce, Andrew C., et al.
Publicado: (2016)

Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells
por: Perera, Nilanka, et al.
Publicado: (2022)

New Approaches for Biomarker Discovery: The Search for Liver Fibrosis Markers in Hepatitis C Patients
por: Gangadharan, Bevin, et al.
Publicado: (2011)

Discovery of Novel Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients: A Preliminary Study
por: Gangadharan, Bevin, et al.
Publicado: (2012)

Clamping, bending, and twisting inter-domain motions in the misfold-recognizing portion of UDP-glucose: Glycoprotein glucosyltransferase
por: Modenutti, Carlos P., et al.
Publicado: (2021)

A quinolin-8-ol sub-millimolar inhibitor of UGGT, the ER glycoprotein folding quality control checkpoint
por: Guay, Kevin P., et al.
Publicado: (2023)

Isomer Information from Ion Mobility Separation of High-Mannose Glycan Fragments
por: Harvey, David J., et al.
Publicado: (2018)

Formation and fragmentation of doubly and triply charged ions in the negative ion spectra of neutral N-glycans from viral and other glycoproteins
por: Harvey, David J., et al.
Publicado: (2021)

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example
por: Kumar, Abhinav, et al.
Publicado: (2017)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target
por: Sobala, Łukasz F., et al.
Publicado: (2020)

Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
por: Warfield, Kelly L., et al.
Publicado: (2016)

Mass photometry reveals SARS-CoV-2 spike stabilisation to impede ACE2 binding through altered conformational dynamics
por: Burnap, Sean A., et al.
Publicado: (2022)

Crystal polymorphism in fragment-based lead discovery of ligands of the catalytic domain of UGGT, the glycoprotein folding quality control checkpoint
por: Caputo, Alessandro T., et al.
Publicado: (2022)

Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
por: Miller, Joanna L., et al.
Publicado: (2016)

Optimal Synthetic Glycosylation of a Therapeutic Antibody
por: Parsons, Thomas B., et al.
Publicado: (2016)

Optimal Synthetic Glycosylation of a Therapeutic Antibody
por: Parsons, Thomas B., et al.
Publicado: (2016)

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis
por: Saldova, Radka, et al.
Publicado: (2008)

Host-targeting oral antiviral drugs to prevent pandemics
por: Dwek, Raymond A, et al.
Publicado: (2022)

Role of disulfide bond formation in the folding and assembly of the envelope glycoproteins of a pestivirus
por: Branza-Nichita, Norica, et al.
Publicado: (2002)

Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus
por: Miller, Joanna L., et al.
Publicado: (2019)

Glycosylation and oligomerization of the spike protein of marburg virus
por: Feldmann, H., et al.
Publicado: (1991)

Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review
por: Bharucha, Tehmina, et al.
Publicado: (2019)

Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
por: Ragotte, Robert J., et al.
Publicado: (2021)

Pathogen‐induced inflammation is attenuated by the iminosugar MON‐DNJ via modulation of the unfolded protein response
por: Sayce, Andrew C., et al.
Publicado: (2021)

Essential chemistry for biochemists
por: Jonsson, Amanda L., et al.
Publicado: (2017)

Engineering Hydrophobic Protein–Carbohydrate Interactions to Fine-Tune Monoclonal Antibodies
por: Yu, Xiaojie, et al.
Publicado: (2013)

Glycoprotein Structural Genomics: Solving the Glycosylation Problem
por: Chang, Veronica T., et al.
Publicado: (2007)

Transcriptome Sequencing, Microarray, and Proteomic Analyses Reveal Cellular and Metabolic Impact of Hepatitis C Virus Infection In Vitro
por: Woodhouse, Stephen D, et al.
Publicado: (2010)

Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
por: Shen, Shuo, et al.
Publicado: (2007)

Evolving spike-protein N-glycosylation in SARS-CoV-2 variants
por: Baboo, Sabyasachi, et al.
Publicado: (2023)

Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation
por: Zhang, Liping, et al.
Publicado: (2021)

Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation
por: Zhang, Liping, et al.
Publicado: (2021)

O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins
por: Zhang, Yong, et al.
Publicado: (2021)

Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
por: Bouwman, Kim M., et al.
Publicado: (2021)

N-glycosylation of infectious bronchitis virus M41 spike determines receptor specificity
por: Bouwman, K. M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e54oc81bmspsghu75djk9pk51p